Many Women Shun Preventive Breast Cancer Meds

Six in 7 women shun a medication that may reduce their risk of breast cancer because some do not trust the drug, while others fear the side effects associated with it, according to a study funded by Cancer Research UK.

In 2013, the UK’s National Institute for Health and Care Excellence (NICE) approved tamoxifen to curb the risk of cancer in women who had a heightened cancer risk and who also had a family history of breast or ovarian cancer. Studies have indicated that tamoxifen could reduce the risk of cancer by a third.

Despite the promising findings, researchers have found that women are still skeptical about the medication. Analysts asked 258 healthy women who had an increased risk of breast cancer whether they would take tamoxifen to reduce the risk of the disease. Of those, only 32 were open to taking the preventative treatment.

The study, which is published in Breast Cancer Research and Treatment, indicated that women with children were more likely to take tamoxifen while others were a little more reluctant because they felt like “cancer was down to fate, they distrusted medication in general or they feared side effects would interfere with looking after their family.”


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement